{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:01:29Z","timestamp":1770454889651,"version":"3.49.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03197-z","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:38:57Z","timestamp":1768199937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of glycoproteins in autophagy and apoptosis in colorectal cancer: A scoping review"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1848-6160","authenticated-orcid":false,"given":"Asma","family":"Ali Ibrahim Mze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3566-1787","authenticated-orcid":false,"given":"Amirah","family":"Abdul Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3826-7360","authenticated-orcid":false,"given":"Mohammad Johari","family":"Ibahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4761-2472","authenticated-orcid":false,"given":"Wan Nor I\u2019zzah","family":"Wan Mohamad Zain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"3197_CR1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2468-1253(19)30329-2","volume":"4","author":"MG Guren","year":"2019","unstructured":"Guren MG. The global challenge of colorectal cancer. Lancet Gastroenterol Hepatol. 2019;4:894\u20135.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3197_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778\u201389.","journal-title":"Int J Cancer"},{"key":"3197_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3197_CR4","unstructured":"WHO. (2023) Colorectal cancer."},{"key":"3197_CR5","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354.","journal-title":"CA Cancer J Clin"},{"key":"3197_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010197","author":"I M\u00e1rmol","year":"2017","unstructured":"M\u00e1rmol I, S\u00e1nchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18010197.","journal-title":"Int J Mol Sci"},{"key":"3197_CR7","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20200265","volume":"40","author":"M Wan","year":"2020","unstructured":"Wan M, Wang Y, Zeng Z, Deng B, Zhu B, Cao T, et al. Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways. Biosci Rep. 2020;40:BSR20200265.","journal-title":"Biosci Rep"},{"key":"3197_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081530","author":"G Roshandel","year":"2024","unstructured":"Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16081530.","journal-title":"Cancers (Basel)"},{"key":"3197_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386\u2013422.","journal-title":"Ann Oncol"},{"key":"3197_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14:101174.","journal-title":"Transl Oncol"},{"key":"3197_CR11","first-page":"20","volume":"7","author":"B Rathva","year":"2020","unstructured":"Rathva B, Desai SV. Colorectal cancer: etiology, pathogenesis and current treatment. J Innov Pharm Biol Sci. 2020;7:20\u20134.","journal-title":"J Innov Pharm Biol Sci"},{"key":"3197_CR12","doi-asserted-by":"publisher","first-page":"2185028","DOI":"10.1080\/19490976.2023.2185028","volume":"15","author":"MW Dougherty","year":"2023","unstructured":"Dougherty MW, Jobin C. Intestinal bacteria and colorectal cancer: etiology and treatment. Gut Microbes. 2023;15:2185028.","journal-title":"Gut Microbes"},{"key":"3197_CR13","volume":"1876","author":"M Luo","year":"2021","unstructured":"Luo M, Yang X, Chen H-N, Nice EC, Huang C. Drug resistance in colorectal cancer: an epigenetic overview. Biochimica et Biophysica Acta (BBA). 2021;1876:188623.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"3197_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122928","volume":"14","author":"Q Wang","year":"2022","unstructured":"Wang Q, Shen X, Chen G, Du J. Drug resistance in colorectal cancer: from mechanism to clinic. Cancers (Basel). 2022;14:2928.","journal-title":"Cancers (Basel)"},{"key":"3197_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, Wang W, Mo Y-Q, Luo Q, et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target Ther. 2024;9:266.","journal-title":"Signal Transduct Target Ther"},{"key":"3197_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118741","volume":"193","author":"S Favier","year":"2025","unstructured":"Favier S, Xiong W, Chalabi-Dchar M, et al. Exploring and bypassing resistance to targeted therapies in colorectal cancer. Biomed Pharmacother. 2025;193:118741.","journal-title":"Biomed Pharmacother"},{"key":"3197_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s10495-021-01687-9","volume":"26","author":"S Das","year":"2021","unstructured":"Das S, Shukla N, Singh SS, Kushwaha S, Shrivastava R. Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis. 2021;26:512\u201333.","journal-title":"Apoptosis"},{"key":"3197_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216662","volume":"585","author":"U Biswas","year":"2024","unstructured":"Biswas U, Roy R, Ghosh S, Chakrabarti G. The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics. Cancer Lett. 2024;585:216662.","journal-title":"Cancer Lett"},{"key":"3197_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1528230","author":"P Jalali","year":"2025","unstructured":"Jalali P, Shahmoradi A, Samii A, Mazloomnejad R, Hatamnejad MR, Saeed A, et al. The role of autophagy in cancer: from molecular mechanism to therapeutic window. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1528230.","journal-title":"Front Immunol"},{"key":"3197_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02802-x","volume":"16","author":"L Lei","year":"2025","unstructured":"Lei L, Zhang J, Wei R, Dong B, Wang X, Zhou Y. Deciphering the dual role of autophagy in gastric cancer and gastroesophageal junction cancer: from tumor suppression to cancer progression. Discov Oncol. 2025;16:1013.","journal-title":"Discov Oncol"},{"key":"3197_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3892\/or.2022.8423","volume":"48","author":"H Xi","year":"2022","unstructured":"Xi H, Wang S, Wang B, Hong X, Liu X, Li M, Shen R, Dong Q. The role of interaction between autophagy and apoptosis in tumorigenesis (Review). Oncol Rep. 2022;48:208.","journal-title":"Oncol Rep"},{"key":"3197_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1042\/bse0550105","volume":"55","author":"T Yonekawa","year":"2013","unstructured":"Yonekawa T, Thorburn A. Autophagy and cell death. Essays Biochem. 2013;55:105\u201317.","journal-title":"Essays Biochem"},{"key":"3197_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2174\/9789815079364123010013","volume-title":"Curr. Cancer Biomarkers","author":"MA Haque","year":"2023","unstructured":"Haque MA. Glycoproteins and cancer biomarkers. In: Curr. Cancer Biomarkers. 2023. p. 195\u2013227."},{"key":"3197_CR24","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/cac2.12610","volume":"44","author":"X Xu","year":"2024","unstructured":"Xu X, Peng Q, Jiang X, et al. Altered glycosylation in cancer: molecular functions and therapeutic potential. Cancer Commun. 2024;44:1316\u201336.","journal-title":"Cancer Commun"},{"key":"3197_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2217\/bmm.15.55","volume":"9","author":"E Song","year":"2015","unstructured":"Song E, Mechref Y. Defining glycoprotein cancer biomarkers by MS in conjunction with glycoprotein enrichment. Biomark Med. 2015;9:835\u201344.","journal-title":"Biomark Med"},{"key":"3197_CR26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15:540\u201355.","journal-title":"Nat Rev Cancer"},{"key":"3197_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1389450122666210412125018","volume":"23","author":"MM Estevinho","year":"2022","unstructured":"Estevinho MM, Fernandes C, Silva JC, Gomes AC, Afecto E, Correia J, Carvalho J. Role of ATP-binding cassette transporters in Sorafenib therapy for hepatocellular carcinoma: an overview. Curr Drug Targets. 2022;23:21\u201332.","journal-title":"Curr Drug Targets"},{"key":"3197_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3412074","volume":"2018","author":"G Lee","year":"2018","unstructured":"Lee G, Joung J-Y, Cho J-H, Son C-G, Lee N. Overcoming P-glycoprotein-mediated multidrug resistance in colorectal cancer: potential reversal agents among herbal medicines. Evid Based Complement Alternat Med. 2018;2018:3412074.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3197_CR29","doi-asserted-by":"publisher","first-page":"e09777","DOI":"10.1016\/j.heliyon.2022.e09777","volume":"8","author":"II Ahmed Juvale","year":"2022","unstructured":"Ahmed Juvale II, Abdul Hamid AA, Abd Halim KB, Che Has AT. P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease. Heliyon. 2022;8:e09777.","journal-title":"Heliyon"},{"key":"3197_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373.","journal-title":"Ann Intern Med"},{"key":"3197_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4300\/JGME-D-22-00621.1","volume":"14","author":"S Mak","year":"2022","unstructured":"Mak S, Thomas A. Steps for conducting a scoping review. J Grad Med Educ. 2022;14:565\u20137.","journal-title":"J Grad Med Educ"},{"key":"3197_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/jiaps.JIAPS_76_18","volume":"24","author":"SK Ratan","year":"2019","unstructured":"Ratan SK, Anand T, Ratan J. Formulation of research question - stepwise approach. J Indian Assoc Pediatr Surg. 2019;24:15\u201320.","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"3197_CR33","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s12094-023-03380-6","volume":"26","author":"S Sritharan","year":"2024","unstructured":"Sritharan S, Sivalingam N. Doxorubicin-induced chemoresistance in duke\u2019s type B colon adenocarcinoma cell line is aggravated in the presence of TGF-\u03b22 through non-apoptotic cell death. Clin Transl Oncol. 2024;26:1630\u20138.","journal-title":"Clin Transl Oncol"},{"key":"3197_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/1751-2980.12131","volume":"15","author":"Y Xing","year":"2014","unstructured":"Xing Y, Wang ZH, Ma DH, Han Y. FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1. J Dig Dis. 2014;15:246\u201359.","journal-title":"J Dig Dis"},{"key":"3197_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.biopha.2018.06.170","volume":"106","author":"K Sroda-Pomianek","year":"2018","unstructured":"Sroda-Pomianek K, Michalak K, Swiatek P, Pola A, Palko-Labuz A, Wesolowska O. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo\/Dx in the presence of newly synthesized phenothiazine derivatives. Biomed Pharmacother. 2018;106:624\u201336.","journal-title":"Biomed Pharmacother"},{"key":"3197_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.biochi.2016.05.010","volume":"127","author":"B Iovine","year":"2016","unstructured":"Iovine B, Guardia F, Irace C, Bevilacqua MA. L-carnosine dipeptide overcomes acquired resistance to 5-fluorouracil in HT29 human colon cancer cells via downregulation of HIF1-alpha and induction of apoptosis. Biochimie. 2016;127:196\u2013204.","journal-title":"Biochimie"},{"key":"3197_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179286","author":"L Mosca","year":"2021","unstructured":"Mosca L, Pagano M, Borzacchiello L, Mele L, Russo A, Russo G, et al. S-adenosylmethionine increases the sensitivity of human colorectal cancer cells to 5-fluorouracil by inhibiting P-glycoprotein expression and NF-\u03baB activation. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22179286.","journal-title":"Int J Mol Sci"},{"key":"3197_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3892\/etm.2011.441","volume":"3","author":"CC Su","year":"2012","unstructured":"Su CC. Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. Exp Ther Med. 2012;3:555\u20139.","journal-title":"Exp Ther Med"},{"key":"3197_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111560","volume":"127","author":"P Chen","year":"2025","unstructured":"Chen P, Chen Y, Sharma A, Maria AG-C, Schmidt-Wolf IGH. Inhibition of ERO1L induces autophagy and apoptosis via endoplasmic reticulum stress in colorectal cancer. Cell Signal. 2025;127:111560.","journal-title":"Cell Signal"},{"key":"3197_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1248\/cpb.c17-00824","volume":"66","author":"KM Elamin","year":"2018","unstructured":"Elamin KM, Yamashita Y, Higashi T, Motoyama K, Arima H. Supramolecular complex of methyl-\u03b2-cyclodextrin with adamantane- grafted hyaluronic acid as a novel antitumor agent. Chem Pharm Bull. 2018;66:277\u201385.","journal-title":"Chem Pharm Bull"},{"key":"3197_CR41","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.4161\/auto.28679","volume":"10","author":"M-F Wei","year":"2014","unstructured":"Wei M-F, Chen M-W, Chen K-C, Lou P-J, Lin SY-F, Hung S-C, Hsiao M, Yao C-J, Shieh M-J. Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells. Autophagy. 2014;10:1179\u201392.","journal-title":"Autophagy"},{"key":"3197_CR42","doi-asserted-by":"publisher","first-page":"9288","DOI":"10.3748\/wjg.v22.i42.9288","volume":"22","author":"S Pan","year":"2016","unstructured":"Pan S, Brentnall TA, Chen R. Glycoproteins and glycoproteomics in pancreatic cancer. World J Gastroenterol. 2016;22:9288\u201399.","journal-title":"World J Gastroenterol"},{"key":"3197_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125406","volume":"244","author":"M Zhang","year":"2023","unstructured":"Zhang M, Ou X, Shi H, Huang W, Song L, Zhu J, et al. Isolation, structures and biological activities of medicinal glycoproteins from natural resources: a review. Int J Biol Macromol. 2023;244:125406.","journal-title":"Int J Biol Macromol"},{"key":"3197_CR44","doi-asserted-by":"publisher","first-page":"797759","DOI":"10.3389\/fimmu.2022.797759","volume":"13","author":"A Parshenkov","year":"2022","unstructured":"Parshenkov A, Hennet T. Glycosylation-dependent induction of programmed cell death in murine adenocarcinoma cells. Front Immunol. 2022;13:797759.","journal-title":"Front Immunol"},{"key":"3197_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13205-023-03864-w","volume":"14","author":"A Mathur","year":"2024","unstructured":"Mathur A, Ritu, Chandra P, Das A. Autophagy: a necessary evil in cancer and inflammation. 3 Biotech. 2024;14:87.","journal-title":"3 Biotech"},{"key":"3197_CR46","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s41388-017-0046-6","volume":"37","author":"SS Singh","year":"2018","unstructured":"Singh SS, Vats S, Chia AY-Q, et al. Dual role of autophagy in hallmarks of cancer. Oncogene. 2018;37:1142\u201358.","journal-title":"Oncogene"},{"key":"3197_CR47","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1016\/j.jmb.2016.06.011","volume":"428","author":"K Fahie","year":"2016","unstructured":"Fahie K, Zachara NE. Molecular functions of glycoconjugates in autophagy. J Mol Biol. 2016;428:3305\u201324.","journal-title":"J Mol Biol"},{"key":"3197_CR48","first-page":"221","volume-title":"Kilcoyne M, Joshi LBT-TG in HH and D","author":"WB Dias","year":"2024","unstructured":"Dias WB, Vasconcelos-dos-Santos A, Loponte HFBR, Teixeira FCOB, Santos RC, de-Freitas-Junior JCM, et al. Chap.\u00a09 - Protein glycosylation in cancer. In: Kilcoyne M, Joshi LBT-TG in HH and D. Academic Press; 2024. p. 221\u201354."},{"key":"3197_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13045-024-01532-x","volume":"17","author":"K He","year":"2024","unstructured":"He K, Baniasad M, Kwon H, Caval T, Xu G, Lebrilla C, Hommes DW, Bertozzi C. Decoding the glycoproteome: a new frontier for biomarker discovery in cancer. J Hematol Oncol. 2024;17:12.","journal-title":"J Hematol Oncol"},{"key":"3197_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/cpr.12155","volume":"48","author":"Q Jiang","year":"2015","unstructured":"Jiang Q, Zhang S, Tian M, Zhang S, Xie T, Chen D, Chen Y, He J, Liu J, Ouyang L. Plant lectins, from ancient sugar-binding proteins to emerging anti\u2010cancer drugs in apoptosis and autophagy. Cell Prolif. 2015;48:17\u201328.","journal-title":"Cell Prolif"},{"key":"3197_CR51","doi-asserted-by":"publisher","first-page":"e11171","DOI":"10.1016\/j.heliyon.2022.e11171","volume":"8","author":"C Pilotto Heming","year":"2022","unstructured":"Pilotto Heming C, Muriithi W, Wanjiku Macharia L, Niemeyer Filho P, Moura-Neto V, Aran V. P-glycoprotein and cancer: what do we currently know? Heliyon. 2022;8:e11171.","journal-title":"Heliyon"},{"key":"3197_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.576559","volume":"10","author":"A Seelig","year":"2020","unstructured":"Seelig A. P-Glycoprotein: one mechanism, many tasks and the consequences for pharmacotherapy of cancers. Front Oncol. 2020;10:576559.","journal-title":"Front Oncol"},{"key":"3197_CR53","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/life12060897","volume":"12","author":"C Karthika","year":"2022","unstructured":"Karthika C, Sureshkumar R, Zehravi M, Akter R, Ali F, Ramproshad S, Mondal B, Tagde P, Ahmed Z, Khan FS. Multidrug resistance of cancer cells and the vital role of P-glycoprotein. Life. 2022;12:897.","journal-title":"Life"},{"key":"3197_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/jct.2025.161001","volume":"16","author":"VSNR Yendapalli","year":"2025","unstructured":"Yendapalli VSNR, Williams K, Oroszi T. Role of P-Gp in treatment of cancer. J Cancer Ther. 2025;16:1\u201317.","journal-title":"J Cancer Ther"},{"key":"3197_CR55","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/s41598-018-19325-x","volume":"8","author":"AK Nanayakkara","year":"2018","unstructured":"Nanayakkara AK, Follit CA, Chen G, Williams NS, Vogel PD, Wise JG. Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells. Sci Rep. 2018;8:967.","journal-title":"Sci Rep"},{"key":"3197_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.adcanc.2024.100114","author":"S Ashique","year":"2024","unstructured":"Ashique S, Bhowmick M, Pal R, Khatoon H, Kumar P, Sharma H, et al. Multi drug resistance in colorectal cancer- approaches to overcome, advancements and future success. Adv CANCER Biol. 2024. https:\/\/doi.org\/10.1016\/j.adcanc.2024.100114.","journal-title":"Adv CANCER Biol"},{"key":"3197_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","volume":"15","author":"Q Wu","year":"2022","unstructured":"Wu Q, You L, Nepovimova E, Heger Z, Wu W, Kuca K, Adam V. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J Hematol Oncol. 2022;15:77.","journal-title":"J Hematol Oncol"},{"key":"3197_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13046-024-02990-4","volume":"43","author":"P Chen","year":"2024","unstructured":"Chen P, Sharma A, Weiher H, Schmidt-Wolf IGH. Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1\u03b1) in human cancer. J Exp Clin Cancer Res. 2024;43:71.","journal-title":"J Exp Clin Cancer Res"},{"key":"3197_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677169","author":"L Liu","year":"2021","unstructured":"Liu L, Wang C, Li S, Qu Y, Xue P, Ma Z, et al. ERO1L is a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.677169.","journal-title":"Front Immunol"},{"key":"3197_CR60","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.7150\/thno.45124","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yang J, Lin C, Liu W, Huo Y, Yang M, et al. Endoplasmic reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in pancreatic cancer. Theranostics. 2020;10:8400\u201314.","journal-title":"Theranostics"},{"key":"3197_CR61","doi-asserted-by":"publisher","first-page":"363","DOI":"10.21873\/cgp.20507","volume":"22","author":"R Ghemrawi","year":"2025","unstructured":"Ghemrawi R, Kremesh S, Mousa WK, Khair M. The role of ER stress and the unfolded protein response in cancer. Cancer Genomics Proteomics. 2025;22:363\u201381.","journal-title":"Cancer Genomics Proteomics"},{"key":"3197_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194870","author":"S Bartoszewska","year":"2022","unstructured":"Bartoszewska S, Collawn JF, Bartoszewski R. The role of the hypoxia-related unfolded protein response (UPR) in the tumor microenvironment. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194870.","journal-title":"Cancers (Basel)"},{"key":"3197_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5553425","volume":"2021","author":"J Yang","year":"2021","unstructured":"Yang J, Xu Y, Huo Y, Cai L, Hua R, Zhang J, et al. ERO1L promotes hepatic metastasis through activating epithelial-mesenchymal transition (EMT) in pancreatic cancer. J Immunol Res. 2021;2021:5553425.","journal-title":"J Immunol Res"},{"key":"3197_CR64","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1083\/jcb.200805001","volume":"182","author":"A-C Tien","year":"2008","unstructured":"Tien A-C, Rajan A, Schulze KL, Ryoo HD, Acar M, Steller H, et al. Ero1L, a thiol oxidase, is required for Notch signaling through cysteine bridge formation of the Lin12-Notch repeats in drosophila melanogaster. J Cell Biol. 2008;182:1113\u201325.","journal-title":"J Cell Biol"},{"key":"3197_CR65","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1074\/jbc.275.7.4827","volume":"275","author":"A Cabibbo","year":"2000","unstructured":"Cabibbo A, Pagani M, Fabbri M, Rocchi M, Farmery MR, Bulleid NJ, et al. ERO1-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum *. J Biol Chem. 2000;275:4827\u201333.","journal-title":"J Biol Chem"},{"key":"3197_CR66","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41419-020-03067-8","volume":"11","author":"Y lei","year":"2020","unstructured":"lei Y, Zang R, Lu Z, et al. ERO1L promotes IL6\/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells. Cell Death Dis. 2020;11:853.","journal-title":"Cell Death Dis"},{"key":"3197_CR67","doi-asserted-by":"publisher","first-page":"23685","DOI":"10.1074\/jbc.M003061200","volume":"275","author":"M Pagani","year":"2000","unstructured":"Pagani M, Fabbri M, Benedetti C, Fassio A, Pilati S, Bulleid NJ, Sitia R. Endoplasmic reticulum oxidoreductin 1-lalpha (ERO1-lalpha), a human gene induced in the course of the unfolded protein response. J Biol Chem. 2000;275:23685\u201392.","journal-title":"J Biol Chem"},{"key":"3197_CR68","doi-asserted-by":"publisher","first-page":"e201800090","DOI":"10.26508\/lsa.201800090","volume":"1","author":"A Moilanen","year":"2018","unstructured":"Moilanen A, Korhonen K, Saaranen MJ, Ruddock LW. Molecular analysis of human Ero1 reveals novel regulatory mechanisms for oxidative protein folding. Life Sci Alliance. 2018;1:e201800090.","journal-title":"Life Sci Alliance"},{"key":"3197_CR69","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1038\/emboj.2010.203","volume":"29","author":"C Appenzeller-Herzog","year":"2010","unstructured":"Appenzeller-Herzog C, Riemer J, Zito E, Chin K, Ron D, Spiess M, Ellgaard L. Disulphide production by Ero1\u03b1\u2013PDI relay is rapid and effectively regulated. EMBO J. 2010;29:3318\u201329.","journal-title":"EMBO J"},{"key":"3197_CR70","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ygcen.2011.05.014","volume":"173","author":"Q Long","year":"2011","unstructured":"Long Q, Zhu X, Wu Y, Feng B, Jin D, Huang J, Lei T, Gan L, Yang Z. Molecular cloning and characterization of the Porcine Ero1L and ERp44 genes: potential roles in controlling energy metabolism. Gen Comp Endocrinol. 2011;173:259\u201369.","journal-title":"Gen Comp Endocrinol"},{"key":"3197_CR71","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11:64.","journal-title":"J Hematol Oncol"},{"key":"3197_CR72","doi-asserted-by":"publisher","first-page":"7970","DOI":"10.1111\/febs.16179","volume":"289","author":"Q Guo","year":"2022","unstructured":"Guo Q, Yang C, Gao F. The state of CD44 activation in cancer progression and therapeutic targeting. FEBS J. 2022;289:7970\u201386.","journal-title":"FEBS J"},{"key":"3197_CR73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12014-018-9198-9","volume":"15","author":"R Azevedo","year":"2018","unstructured":"Azevedo R, Gaiteiro C, Peixoto A, Relvas-Santos M, Lima L, Santos LL, Ferreira JA. CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications. Clin Proteom. 2018;15:22.","journal-title":"Clin Proteom"},{"key":"3197_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174147","volume":"903","author":"Z Yaghobi","year":"2021","unstructured":"Yaghobi Z, Movassaghpour A, Talebi M, Abdoli Shadbad M, Hajiasgharzadeh K, Pourvahdani S, et al. The role of CD44 in cancer chemoresistance: a concise review. Eur J Pharmacol. 2021;903:174147.","journal-title":"Eur J Pharmacol"},{"key":"3197_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s11658-024-00554-0","volume":"29","author":"P Pleska\u010d","year":"2024","unstructured":"Pleska\u010d P, Fargeas CA, Veselska R, Corbeil D, Skoda J. Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease. Cell Mol Biol Lett. 2024;29:41.","journal-title":"Cell Mol Biol Lett"},{"key":"3197_CR76","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2012.07.025","volume":"338","author":"KE Ritchie","year":"2013","unstructured":"Ritchie KE, N\u00f6r JE. Perivascular stem cell niche in head and neck cancer. Cancer Lett. 2013;338:41\u20136.","journal-title":"Cancer Lett"},{"key":"3197_CR77","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41417-019-0109-7","volume":"27","author":"SK Saha","year":"2020","unstructured":"Saha SK, Islam SMR, Kwak K-S, Rahman MS, Cho S-G. PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis. Cancer Gene Ther. 2020;27:147\u201367.","journal-title":"Cancer Gene Ther"},{"key":"3197_CR78","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5483\/BMBRep.2022-0203","volume":"56","author":"M-S Bahn","year":"2023","unstructured":"Bahn M-S, Ko Y-G. PROM1-mediated cell signal transduction in cancer stem cells and hepatocytes. BMB Rep. 2023;56:65\u201370.","journal-title":"BMB Rep"},{"key":"3197_CR79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","volume":"10","author":"SR Stowell","year":"2015","unstructured":"Stowell SR, Ju T, Cummings RD. Protein glycosylation in cancer. Annu Rev Pathol. 2015;10:473\u2013510.","journal-title":"Annu Rev Pathol"},{"key":"3197_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030645","author":"N Berois","year":"2022","unstructured":"Berois N, Pittini A, Osinaga E. Targeting tumor glycans for cancer therapy: successes, limitations, and perspectives. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14030645.","journal-title":"Cancers (Basel)"},{"key":"3197_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073722","volume":"25","author":"J Soares","year":"2024","unstructured":"Soares J, Eiras M, Ferreira D, et al. Stool glycoproteomics signatures of pre-cancerous lesions and colorectal cancer. Int J Mol Sci. 2024;25:3722.","journal-title":"Int J Mol Sci"},{"key":"3197_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1570712","volume":"15","author":"H Al-Jaber","year":"2025","unstructured":"Al-Jaber H, Biswas KH, Al-Mansoori L. Advancing targeted therapy for colorectal cancer: harnessing ligand-directed enzyme prodrug therapy for highly specific interventions. Front Oncol. 2025;15:1570712.","journal-title":"Front Oncol"},{"key":"3197_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415645","volume":"12","author":"G Liu","year":"2025","unstructured":"Liu G, Chen L, Zhao J, et al. Deciphering the metabolic impact and clinical relevance of N-glycosylation in colorectal cancer through comprehensive glycoproteomic profiling. Adv Sci. 2025;12:2415645.","journal-title":"Adv Sci"},{"key":"3197_CR84","volume":"1880","author":"M Granica","year":"2025","unstructured":"Granica M, Laskowski G, Link-Lenczowski P, Graczyk-Jarzynka A. Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies. Biochimica et Biophysica Acta (BBA). 2025;1880:189274.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"3197_CR85","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1007\/s00216-025-06108-3","volume":"417","author":"W Zhang","year":"2025","unstructured":"Zhang W, Wang X, Wen S, Ge W, Deng J, Zhou Z, Jiang J, Yang X, Wang Y, Yang S. Glycoproteomics analysis of colorectal cancer reveals differential alterations of glycoproteins and glycans. Anal Bioanal Chem. 2025;417:6179\u201390.","journal-title":"Anal Bioanal Chem"},{"key":"3197_CR86","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41388-023-02702-w","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen H. Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications. Oncogene. 2023;42:1970\u20139.","journal-title":"Oncogene"},{"key":"3197_CR87","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.e15529","volume":"40","author":"K Lindpaintner","year":"2022","unstructured":"Lindpaintner K, Desai K, Xu G, Rice R, Castellanos A, Serie D, et al. Identifying potential glycoproteomic biomarkers for diagnosis of colorectal cancer (CRC). J Clin Oncol. 2022;40:e15529\u2013e15529.","journal-title":"J Clin Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03197-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:03:54Z","timestamp":1770393834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03197-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":87,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3197"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03197-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"110"}}